Steven Cohen Lava Therapeutics Nv Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.28 - $4.4 $11,372 - $21,947	-4,988 Reduced 4.26%	111,993 $330,000
Q1 2022 May 16, 2022	SELL	$4.28 - $6.55 $9,291 - $14,220	-2,171 Reduced 1.82%	116,981 $515,000
Q4 2021 Feb 14, 2022	SELL	$4.23 - $7.77 $20,130 - $36,977	-4,759 Reduced 3.84%	119,152 $655,000
Q3 2021 Nov 15, 2021	BUY	$5.5 - $11.0 $681,510 - $1.36 Million	123,911 New	123,911 $734,000
Q2 2021 Aug 16, 2021	SELL	$10.8 - $16.0 $60,058 - $88,976	-5,561 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$12.5 - $15.19 $69,512 - $84,471	5,561 New	5,561 $84,000

3.61M

32.9K

500

Ticker LVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,797,700
Market Cap $25.5M
Description
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.